| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8823978 | Journal of Vascular and Interventional Radiology | 2018 | 14 Pages |
Abstract
Patients with unresectable HCC started on systemic therapy with SOR appear to benefit from adjuvant transarterial chemoembolization. Optimal application of multimodal therapy in this setting should be prospectively investigated.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
David E. MD, MSc, Rajni MPH, Kathryn BS, Terence P. MD, PhD, Tamar H. MD,